VenoStent is conducting a 200-subject, prospective, one-to-one randomized controlled trial in dialysis accessHOUSTON, TX / ACCESSWIRE / January 30, 2024 / VenoStent, Inc., a clinical-stage, venture-backed, therapeutic medical device company developing …
ACR Oversaw Listing, Verification, and Issuance of Credits to A-GasBOWLING GREEN, OH / ACCESSWIRE / January 30, 2024 / A-Gas, a leader in the lifecycle management of refrigerants, announces it is one of the first two carbon projects approved for issuan…
ORLANDO, FL / ACCESSWIRE / January 30, 2024 / U.S. Hunger (USH) is pleased to report more than 13 million meals packed and delivered to families facing food insecurity in 2023 through its Hunger Project meal-packing events. This brings the nonprofit’s …
DELRAY BEACH, FL / ACCESSWIRE / January 30, 2024 / Adolore BioTherapeutics (“Adolore” or the “Company”), a biotechnology company focused on developing breakthrough opioid-free gene therapy treatments for chronic pain, today announce…